1952 related articles for article (PubMed ID: 26551169)
1. [On-site fine-needle aspiration cytology of thyroid nodules. Quality assurance of the Bethesda System for Reporting Thyroid Cytopathology (2008)].
Bak M; Péter I; Nyári T; Simon P; Újlaky M; Boér A; Kásler M
Orv Hetil; 2015 Oct; 156(41):1661-6. PubMed ID: 26551169
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the bethesda system for reporting thyroid cytopathology and similar precursor thyroid cytopathology reporting schemes.
Wong LQ; Baloch ZW
Adv Anat Pathol; 2012 Sep; 19(5):313-9. PubMed ID: 22885380
[TBL] [Abstract][Full Text] [Related]
3. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
[TBL] [Abstract][Full Text] [Related]
4. Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology.
Na DG; Kim JH; Sung JY; Baek JH; Jung KC; Lee H; Yoo H
Thyroid; 2012 May; 22(5):468-75. PubMed ID: 22304417
[TBL] [Abstract][Full Text] [Related]
5. Comparison of thyroid fine needle aspiration biopsy results before and after implementation of Bethesda classification.
Ozdemir D; Bestepe N; Faki S; Kilicarslan A; Parlak O; Ersoy R; Cakir B
Cytopathology; 2017 Oct; 28(5):400-406. PubMed ID: 28727204
[TBL] [Abstract][Full Text] [Related]
6. A histological assessment of the Bethesda system for reporting thyroid cytopathology (2010) abnormal categories: a series of 219 consecutive cases.
Tepeoğlu M; Bilezikçi B; Bayraktar SG
Cytopathology; 2014 Feb; 25(1):39-44. PubMed ID: 23438201
[TBL] [Abstract][Full Text] [Related]
7. Application of the Bethesda Classification for Thyroid Fine-Needle Aspiration: Institutional Experience and Meta-analysis.
Krauss EA; Mahon M; Fede JM; Zhang L
Arch Pathol Lab Med; 2016 Oct; 140(10):1121-31. PubMed ID: 27684984
[TBL] [Abstract][Full Text] [Related]
8. Bethesda System Categories of Fine Needle Aspiration Cytology Are Not Associated with Thyroid Nodule Location: A Single Institution Experience.
Xavier-Júnior JCC; Abrantkoski Borges F; Pizzello Zogheib RJ; Camilo-Júnior DJ
Acta Cytol; 2021; 65(1):22-26. PubMed ID: 32877898
[TBL] [Abstract][Full Text] [Related]
9. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.
Yazgan A; Balci S; Dincer N; Kiyak G; Tuzun D; Ersoy R; Cakir B; Guler G
Cytopathology; 2014 Jun; 25(3):185-9. PubMed ID: 24024935
[TBL] [Abstract][Full Text] [Related]
10. Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: A study of interobserver variability among cytopathologists.
Padmanabhan V; Marshall CB; Akdas Barkan G; Ghofrani M; Laser A; Tolgay Ocal I; David Sturgis C; Souers R; Kurtycz DF
Diagn Cytopathol; 2017 May; 45(5):399-405. PubMed ID: 28217980
[TBL] [Abstract][Full Text] [Related]
11. Assessment of malignancy rate in thyroid nodules according to the Bethesda system of fine-needle aspiration. Report from a tertiary center in the Southwestern region of Saudi Arabia.
Al-Shraim MM; Kaood OM; Hussein MR; Al-Ahmary AM; Al Shehri GY; Jastania RA; Mahfouz AA; Abu-Eshy SA
Saudi Med J; 2012 Feb; 33(2):167-71. PubMed ID: 22327757
[TBL] [Abstract][Full Text] [Related]
12. The Presence of Hürthle Cells Does Not Increase the Risk of Malignancy in Most Bethesda Categories in Thyroid Fine-Needle Aspirates.
Ren Y; Kyriazidis N; Faquin WC; Soylu S; Kamani D; Saade R; Torchia N; Lubitz C; Davies L; Stathatos N; Stephen AE; Randolph GW
Thyroid; 2020 Mar; 30(3):425-431. PubMed ID: 32013786
[No Abstract] [Full Text] [Related]
13. Risk of Malignancy and Risk of Neoplasia in the Bethesda Indeterminate Categories: Study on 4,532 Thyroid Fine-Needle Aspirations from a Single Institution in India.
Mahajan S; Srinivasan R; Rajwanshi A; Radotra B; Panda N; Dey P; Gupta N; Nijhawan R
Acta Cytol; 2017; 61(2):103-110. PubMed ID: 28407624
[TBL] [Abstract][Full Text] [Related]
14. 'Indeterminate for malignancy' (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: morphological criteria and clinical impact.
Pagni F; Prada M; Goffredo P; Isimbaldi G; Crippa S; Di Bella C; Leone BE;
Cytopathology; 2014 Jun; 25(3):170-6. PubMed ID: 23937572
[TBL] [Abstract][Full Text] [Related]
15. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
[TBL] [Abstract][Full Text] [Related]
16. Cytology-Ultrasonography Risk-Stratification Scoring System Based on Fine-Needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System.
Hong MJ; Na DG; Baek JH; Sung JY; Kim JH
Thyroid; 2017 Jul; 27(7):953-959. PubMed ID: 28463597
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-guided fine-needle aspiration of thyroid nodules: does the size limit its efficiency?
Zhong LC; Lu F; Ma F; Xu HX; Li DD; Guo LH; Sun LP
Int J Clin Exp Pathol; 2015; 8(3):3155-9. PubMed ID: 26045833
[TBL] [Abstract][Full Text] [Related]
18. Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology.
Jo VY; Stelow EB; Dustin SM; Hanley KZ
Am J Clin Pathol; 2010 Sep; 134(3):450-6. PubMed ID: 20716802
[TBL] [Abstract][Full Text] [Related]
19. Correlation of thyroid fine-needle aspiration with final histopathology: a case series.
Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M
Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233
[TBL] [Abstract][Full Text] [Related]
20. The 5-tiered categorization system for reporting cytology is sufficient for management of patients with thyroid nodules compared to the 6-tiered Bethesda system.
Koh J; Moon HJ; Kim EK; Kwak JY; Yoon JH
Endocrine; 2016 Aug; 53(2):489-96. PubMed ID: 26758996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
